Drug intelligence / Profile preview

dibrompropamidine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Topical, Ophthalmic
01

Overview

Dibrompropamidine is an aromatic diamidine compound classified as an antiseptic and disinfectant. It is primarily used in the form of its salt, dibrompropamidine isethionate, in topical preparations such as eyedrops and ointments for the treatment of minor eye and eyelid infections in adults and children. The drug exhibits broad-spectrum antibacterial activity, including efficacy against antibiotic-resistant staphylococci and some Gram-negative bacilli. Its mechanism of action involves disruption of microbial cell membranes—leading to leakage of cellular contents—and inhibition of nucleic acid synthesis, which prevents bacterial growth. Dibrompropamidine retains activity even in the presence of organic matter like pus or lacrimal secretions[1][5][6][8].

Brand names
BroleneGolden EyeBrulidine
Other names
dibrompropamidine isethionate

Beyond the preview

Go deeper on dibrompropamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dibrompropamidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call